{"product_id":"semaglutide","title":"Semaglutide","description":"\u003c!-- =========================================================\n  SEMAGLUTIDE — DISSOLV LABS\n  Available in 10 mg and 20 mg lyophilized vial formats\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\n\u003ch2\u003eSemaglutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a synthetic long-acting peptide referenced in the scientific literature as a selective \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e. It is one of the most extensively profiled compounds within the incretin-class research peptide family. DISSOLV LABS supplies Semaglutide in \u003cstrong\u003e10 mg\u003c\/strong\u003e and \u003cstrong\u003e20 mg\u003c\/strong\u003e lyophilized vial formats as a high-purity analytical reference compound for qualified laboratory research professionals.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormats:\u003c\/strong\u003e 10 mg lyophilized vial · 20 mg lyophilized vial\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a structurally modified glucagon-like peptide-1 (GLP-1) analog engineered with a fatty acid side chain that extends half-life relative to native GLP-1. Within the published literature, it is classified as a selective single-receptor agonist of the GLP-1 receptor system, making it a foundational reference compound for comparative incretin research.\u003c\/p\u003e\n\n\u003cp\u003eSemaglutide is frequently positioned as the single-agonist baseline against which newer multi-receptor research peptides — including Tirzepatide (dual GLP-1\/GIP) and Retatrutide (triple GLP-1\/GIP\/glucagon) — are studied. It is among the most cited compounds in modern metabolic and endocrine peptide research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eSemaglutide has been investigated in an extensive body of preclinical and clinical research and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGLP-1 receptor pharmacology and signaling\u003c\/li\u003e\n  \u003cli\u003eLong-acting peptide design and fatty acid acylation strategies\u003c\/li\u003e\n  \u003cli\u003eIncretin biology and receptor selectivity studies\u003c\/li\u003e\n  \u003cli\u003eComparative pharmacokinetics across GLP-1 analogs\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eReference-standard comparisons for multi-agonist peptide development\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (modified GLP-1 analog)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSelective GLP-1 receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, GLP-1 receptor pharmacology, peptide pharmacokinetics, metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Retatrutide, Cagrilintide, Cagrisema, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Semaglutide lot supplied by DISSOLV LABS — across both 10 mg and 20 mg vial formats — undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAvailable formats\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 mg lyophilized vial · 20 mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifiers\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-SEMA-010 (10 mg) · DSL-SEMA-020 (20 mg)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is a synthetic long-acting peptide referenced in scientific literature as a selective GLP-1 receptor agonist. It is a structurally modified GLP-1 analog engineered with a fatty acid side chain that extends half-life relative to native GLP-1. Supplied by DISSOLV LABS as an analytical reference compound for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat vial sizes are available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Semaglutide in two lyophilized vial formats: \u003cstrong\u003e10 mg\u003c\/strong\u003e (catalog DSL-SEMA-010) and \u003cstrong\u003e20 mg\u003c\/strong\u003e (catalog DSL-SEMA-020). Both formats are produced from the same ≥99% purity reference material and accompanied by a per-lot Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is the difference between the 10 mg and 20 mg vials?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe 10 mg and 20 mg formats are analytically identical — same compound, same purity specification (≥99%), same lyophilization protocol, same packaging standard. They differ only in total peptide content per vial. Selection between the two is determined by the receiving laboratory's research workflow and material requirements.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat category does Semaglutide belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is classified within the incretin-class research peptide family as a selective single-receptor GLP-1 agonist. It is studied alongside related compounds such as Tirzepatide (dual GLP-1\/GIP agonist) and Retatrutide (unimolecular triple agonist), and serves as a foundational reference standard for comparative incretin research.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Semaglutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot — in both vial formats — is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Semaglutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Semaglutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Semaglutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Semaglutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Semaglutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat compounds are related to Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is commonly referenced alongside Tirzepatide, Retatrutide, Cagrilintide, Cagrisema, AOD9604, and HGH Fragment 176-191 — all of which are studied within metabolic and endocrine research domains.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Semaglutide compare to Tirzepatide and Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eIn published research literature, Semaglutide is described as a selective single-receptor GLP-1 agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors. Each compound occupies a distinct position within the incretin-class research peptide hierarchy, with Semaglutide serving as the established single-agonist reference standard.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot — in both 10 mg and 20 mg formats — is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTirzepatide\u003c\/strong\u003e — dual GLP-1 \/ GIP receptor agonist research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRetatrutide\u003c\/strong\u003e — unimolecular GLP-1 \/ GIP \/ glucagon triple agonist research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCagrilintide\u003c\/strong\u003e — long-acting amylin analog research peptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCagrisema\u003c\/strong\u003e — combination research compound pairing Cagrilintide with Semaglutide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAOD9604\u003c\/strong\u003e — modified hGH fragment research peptide (amino acids 177–191 with tyrosine modification)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e — C-terminal human growth hormone fragment research peptide\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"10mg","offer_id":52101834178840,"sku":null,"price":28.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52101834211608,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Semaglutide_10.png?v=1779619257","url":"https:\/\/dissolv.com\/products\/semaglutide","provider":"Dissolv Labs","version":"1.0","type":"link"}